Physician

Joseph Anthony Treat

According to 2025 Medicare claims, Joseph Treat (NPI: 1518980218) practices hematopoietic cell transplantation and cellular therapy in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 19111-2434.

Treat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 152 traditional Medicare patients, billed 538 HCPCS/CPT codes, and received $43,887 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 269 prescription claims across 72 beneficiaries totaling $2,205,782 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2023 DME data shows 24 claims. Open Payments data shows 4 records totaling $18,574. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $6,322 to $43,887. Similarly, Part D prescription costs have risen steadily, from $33,617 to $2,205,782. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.